Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,888 | N/A | 2,362 | 6,060 | 1,038 |
| Receivables | 48 | N/A | 353 | 251 | 444 |
| Other current assets | 193 | 0 | 194 | 116 | 122 |
| TOTAL | $2,129 | $N/A | $2,909 | $6,427 | $1,604 |
| Non-Current Assets | |||||
| PPE Net | 0 | N/A | 87 | 87 | 47 |
| Other Non-Current Assets | 0 | 0 | 20 | 20 | 25 |
| TOTAL | $N/A | $N/A | $107 | $107 | $72 |
| Total Assets | $2,129 | $N/A | $3,016 | $6,534 | $1,676 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 136 | 0 | 284 | 319 | 264 |
| Accrued Expenses | 227 | N/A | 588 | 612 | 621 |
| Other current liabilities | 73 | N/A | 98 | 78 | 0 |
| TOTAL | $436 | $N/A | $970 | $1,009 | $885 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7 | N/A | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 16 | 0 | 5 |
| TOTAL | $7 | $N/A | $16 | $N/A | $5 |
| Total Liabilities | $443 | $N/A | $986 | $1,009 | $890 |
| Shareholders' Equity | |||||
| Common Shares | 350 | N/A | 341 | 333 | 328 |
| Retained earnings | -39,026 | N/A | -38,408 | -34,841 | -39,094 |
| Other shareholders' equity | -5 | 0 | -5 | -5 | -6 |
| TOTAL | $1,686 | $N/A | $2,030 | $5,525 | $786 |
| Total Liabilities And Equity | $2,129 | $0 | $3,016 | $6,534 | $1,676 |